|
|
||||||||
Published online before print February 6, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Immunology, Georg-August-University Gottingen, Gottingen, Germany
1 Correspondence: Department of Immunology, Georg-August-University Gottingen, Humboldtallee 32, D-37073 Gottingen, Germany. E-mail: jzwirne{at}gwdg.de
Key Words: anaphylatoxin inflammation receptor
Connelly et al. [1 ] have published in a recent paper that C5a receptor expression in murine T lymphocytes is inducible under certain experimental conditions. Their conclusions rely exclusively on immunophenotyping by flow cytometry using a single mAb (20/70). In Acknowledgments, it is declared that "We are grateful to Dr. Jörg Zwirner (Georg-August-University Gottingen) for the mAb against C5a receptor."
I had originally provided mAb 20/70 against murine C5a receptor to the senior author of that paper, Dr. Jagannath, on a collaborative basis. However, I felt obliged to suggest withdrawal of coauthorship in the genuine belief that more experiments were required to verify expression of a functional C5a receptor on T lymphocytes. Specifically, I had asked for: 1) investigation of antibody binding after preincubation of lymphocytes with C5a, as reduced 20/70 binding might be expected through ligand-specific receptor blockade and/or internalization; and 2) investigation of C5a-induced calcium fluxes in C5a receptor-expressing T lymphocytes, as C3a-induced calcium fluxes in activated T cells have been observed previously [2 ].
Unfortunately, Dr. Jagannath felt unable to perform these experiments.
Received November 22, 2006; accepted December 7, 2006.
REFERENCES
This article has been cited by other articles:
![]() |
S. Nemali, D. W. Siemsen, L. K. Nelson, P. L. Bunger, C. L. Faulkner, P. Rainard, K. A. Gauss, M. A. Jutila, and M. T. Quinn Molecular analysis of the bovine anaphylatoxin C5a receptor J. Leukoc. Biol., August 1, 2008; 84(2): 537 - 549. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |